We evaluated the gut resistome of children from communities treated with 10 twice-yearly azithromycin distributions. Although the macrolide resistance remained higher in the azithromycin arm, the selection of non-macrolide resistance observed at earlier time points did not persist. Longitudinal resistance monitoring should be a critical component of mass distribution programs. Clinical trials registration: NCT02047981
CITATION STYLE
Arzika, A. M., Maliki, R., Abdou, A., Mankara, A. K., Harouna, A. N., Cook, C., … Doan, T. (2021). Gut Resistome of Preschool Children after Prolonged Mass Azithromycin Distribution: A Cluster-randomized Trial. Clinical Infectious Diseases, 73(7), 1292–1295. https://doi.org/10.1093/cid/ciab485
Mendeley helps you to discover research relevant for your work.